APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral GnRH Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oral GnRH Drugs Industry Growth and Trends Forecast to 2032

28 December 202599 pages

Choose your research edition.

Industry ResearchOral GnRH Drugs Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral GnRH Drugs Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Oral GnRH Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral GnRH Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral GnRH Drugs Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Oral GnRH Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oral GnRH Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oral GnRH Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral GnRH Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral GnRH Drugs include Pfizer, Abbvie, Sumitomo Pharma, ObsEva, JW Pharmaceutical and ASKA Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oral GnRH Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oral GnRH Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oral GnRH Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oral GnRH Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oral GnRH Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oral GnRH Drugs Market by Company

Pfizer

Abbvie

Sumitomo Pharma

ObsEva

JW Pharmaceutical

ASKA Pharmaceutical

Oral GnRH Drugs Segment by Type

Relugolix

Linzagolix

Elagolix

Others

Oral GnRH Drugs Segment by Application

Menorrhagia

Uterine Fibroids

Endometriosis

Other

Oral GnRH Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral GnRH Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral GnRH Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral GnRH Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral GnRH Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oral GnRH Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Relugolix Table 2. Major Company of Linzagolix Table 3. Major Company of Elagolix Table 4. Major Company of Others Table 5. Global Oral GnRH Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Oral GnRH Drugs Sales by Type (2021-2026) & (K Units) Table 7. Global Oral GnRH Drugs Sales Market Share in Volume by Type (2021-2026) Table 8. Global Oral GnRH Drugs Sales by Type (2021-2026) & (US$ Million) Table 9. Global Oral GnRH Drugs Sales Market Share in Value by Type (2021-2026) Table 10. Global Oral GnRH Drugs Price by Type (2021-2026) & (US$/Unit) Table 11. Global Oral GnRH Drugs Sales by Type (2027-2032) & (K Units) Table 12. Global Oral GnRH Drugs Sales Market Share in Volume by Type (2027-2032) Table 13. Global Oral GnRH Drugs Sales by Type (2027-2032) & (US$ Million) Table 14. Global Oral GnRH Drugs Sales Market Share in Value by Type (2027-2032) Table 15. Global Oral GnRH Drugs Price by Type (2027-2032) & (US$/Unit) Table 16. North America Oral GnRH Drugs Sales by Type (2021-2026) & (K Units) Table 17. North America Oral GnRH Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Oral GnRH Drugs Sales by Type (2021-2026) & (K Units) Table 19. Europe Oral GnRH Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Oral GnRH Drugs Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Oral GnRH Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Oral GnRH Drugs Sales by Type (2021-2026) & (K Units) Table 23. Latin America Oral GnRH Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Oral GnRH Drugs Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Oral GnRH Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Oral GnRH Drugs Industry Trends Table 27. Oral GnRH Drugs Industry Drivers Table 28. Oral GnRH Drugs Industry Opportunities and Challenges Table 29. Oral GnRH Drugs Industry Restraints Table 30. Global Oral GnRH Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Oral GnRH Drugs Revenue Market Share by Company (2021-2026) Table 32. Global Oral GnRH Drugs Sales by Company (2021-2026) & (K Units) Table 33. Global Oral GnRH Drugs Sales Share by Company (2021-2026) Table 34. Global Oral GnRH Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Oral GnRH Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Oral GnRH Drugs Major Company Production Sites and Headquarters Table 37. Global Oral GnRH Drugs Company, Product Type & Application Table 38. Global Oral GnRH Drugs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Oral GnRH Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Oral GnRH Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Oral GnRH Drugs Sales by Region (2021-2026) & (K Units) Table 43. Global Oral GnRH Drugs Sales Market Share in Volume by Region (2021-2026) Table 44. Global Oral GnRH Drugs Sales by Region (2021-2026) & (US$ Million) Table 45. Global Oral GnRH Drugs Sales Market Share in Value by Region (2021-2026) Table 46. Global Oral GnRH Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Oral GnRH Drugs Sales by Region (2027-2032) & (K Units) Table 48. Global Oral GnRH Drugs Sales Market Share in Volume by Region (2027-2032) Table 49. Global Oral GnRH Drugs Sales by Region (2027-2032) & (US$ Million) Table 50. Global Oral GnRH Drugs Sales Market Share in Value by Region (2027-2032) Table 51. Global Oral GnRH Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Oral GnRH Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Oral GnRH Drugs Sales by Application (2021-2026) & (K Units) Table 54. Global Oral GnRH Drugs Sales Market Share in Volume by Application (2021-2026) Table 55. Global Oral GnRH Drugs Sales by Application (2021-2026) & (US$ Million) Table 56. Global Oral GnRH Drugs Sales Market Share in Value by Application (2021-2026) Table 57. Global Oral GnRH Drugs Price by Application (2021-2026) & (US$/Unit) Table 58. Global Oral GnRH Drugs Sales by Application (2027-2032) & (K Units) Table 59. Global Oral GnRH Drugs Sales Market Share in Volume by Application (2027-2032) Table 60. Global Oral GnRH Drugs Sales by Application (2027-2032) & (US$ Million) Table 61. Global Oral GnRH Drugs Sales Market Share in Value by Application (2027-2032) Table 62. Global Oral GnRH Drugs Price by Application (2027-2032) & (US$/Unit) Table 63. North America Oral GnRH Drugs Sales by Application (2021-2026) & (K Units) Table 64. North America Oral GnRH Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Oral GnRH Drugs Sales by Application (2021-2026) & (K Units) Table 66. Europe Oral GnRH Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Oral GnRH Drugs Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Oral GnRH Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Oral GnRH Drugs Sales by Application (2021-2026) & (K Units) Table 70. Latin America Oral GnRH Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Oral GnRH Drugs Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Oral GnRH Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Oral GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Pfizer Oral GnRH Drugs Product Portfolio Table 77. Pfizer Recent Development Table 78. Abbvie Company Information Table 79. Abbvie Business Overview Table 80. Abbvie Oral GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Abbvie Oral GnRH Drugs Product Portfolio Table 82. Abbvie Recent Development Table 83. Sumitomo Pharma Company Information Table 84. Sumitomo Pharma Business Overview Table 85. Sumitomo Pharma Oral GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Sumitomo Pharma Oral GnRH Drugs Product Portfolio Table 87. Sumitomo Pharma Recent Development Table 88. ObsEva Company Information Table 89. ObsEva Business Overview Table 90. ObsEva Oral GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. ObsEva Oral GnRH Drugs Product Portfolio Table 92. ObsEva Recent Development Table 93. JW Pharmaceutical Company Information Table 94. JW Pharmaceutical Business Overview Table 95. JW Pharmaceutical Oral GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. JW Pharmaceutical Oral GnRH Drugs Product Portfolio Table 97. JW Pharmaceutical Recent Development Table 98. ASKA Pharmaceutical Company Information Table 99. ASKA Pharmaceutical Business Overview Table 100. ASKA Pharmaceutical Oral GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. ASKA Pharmaceutical Oral GnRH Drugs Product Portfolio Table 102. ASKA Pharmaceutical Recent Development Table 103. North America Oral GnRH Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 104. North America Oral GnRH Drugs Sales by Country (2021-2026) & (K Units) Table 105. North America Oral GnRH Drugs Sales Market Share by Country (2021-2026) Table 106. North America Oral GnRH Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 107. North America Oral GnRH Drugs Sales Market Share Forecast by Country (2027-2032) Table 108. North America Oral GnRH Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Oral GnRH Drugs Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Oral GnRH Drugs Market Share by Country (2021-2026) Table 111. North America Oral GnRH Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Oral GnRH Drugs Market Share Forecast by Country (2027-2032) Table 113. Europe Oral GnRH Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 114. Europe Oral GnRH Drugs Sales by Country (2021-2026) & (K Units) Table 115. Europe Oral GnRH Drugs Sales Market Share by Country (2021-2026) Table 116. Europe Oral GnRH Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 117. Europe Oral GnRH Drugs Sales Market Share Forecast by Country (2027-2032) Table 118. Europe Oral GnRH Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Oral GnRH Drugs Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Oral GnRH Drugs Market Share by Country (2021-2026) Table 121. Europe Oral GnRH Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Oral GnRH Drugs Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Oral GnRH Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Oral GnRH Drugs Sales by Country (2021-2026) & (K Units) Table 125. Asia-Pacific Oral GnRH Drugs Sales Market Share by Country (2021-2026) Table 126. Asia-Pacific Oral GnRH Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 127. Asia-Pacific Oral GnRH Drugs Sales Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Oral GnRH Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Oral GnRH Drugs Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Oral GnRH Drugs Market Share by Country (2021-2026) Table 131. Asia-Pacific Oral GnRH Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Oral GnRH Drugs Market Share Forecast by Country (2027-2032) Table 133. Latin America Oral GnRH Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. Latin America Oral GnRH Drugs Sales by Country (2021-2026) & (K Units) Table 135. Latin America Oral GnRH Drugs Sales Market Share by Country (2021-2026) Table 136. Latin America Oral GnRH Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 137. Latin America Oral GnRH Drugs Sales Market Share Forecast by Country (2027-2032) Table 138. Latin America Oral GnRH Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Oral GnRH Drugs Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Oral GnRH Drugs Market Share by Country (2021-2026) Table 141. Latin America Oral GnRH Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Oral GnRH Drugs Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Oral GnRH Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Oral GnRH Drugs Sales by Country (2021-2026) & (K Units) Table 145. Middle East and Africa Oral GnRH Drugs Sales Market Share by Country (2021-2026) Table 146. Middle East and Africa Oral GnRH Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 147. Middle East and Africa Oral GnRH Drugs Sales Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Oral GnRH Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Oral GnRH Drugs Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East and Africa Oral GnRH Drugs Market Share by Country (2021-2026) Table 151. Middle East and Africa Oral GnRH Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Oral GnRH Drugs Market Share Forecast by Country (2027-2032) Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Oral GnRH Drugs Distributors List Table 156. Oral GnRH Drugs Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Oral GnRH Drugs Image Figure 2. Global Oral GnRH Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral GnRH Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral GnRH Drugs Sales (2021-2032) & (K Units) Figure 5. Relugolix Image Figure 6. Global Relugolix Sales YoY Growth (2021-2032) & (K Units) Figure 7. Linzagolix Image Figure 8. Global Linzagolix Sales YoY Growth (2021-2032) & (K Units) Figure 9. Elagolix Image Figure 10. Global Elagolix Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Oral GnRH Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Oral GnRH Drugs Market Share by Type 2025 VS 2032 Figure 15. North America Oral GnRH Drugs Sales Market Share in Volume by Type in 2025 Figure 16. North America Oral GnRH Drugs Sales Market Share in Value by Type in 2025 Figure 17. Europe Oral GnRH Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Europe Oral GnRH Drugs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Oral GnRH Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Oral GnRH Drugs Sales Market Share in Value by Type in 2025 Figure 21. Latin America Oral GnRH Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Oral GnRH Drugs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Oral GnRH Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Oral GnRH Drugs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Oral GnRH Drugs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Menorrhagia Image Figure 28. Global Menorrhagia Sales YoY Growth (2021-2032) & (K Units) Figure 29. Uterine Fibroids Image Figure 30. Global Uterine Fibroids Sales YoY Growth (2021-2032) & (K Units) Figure 31. Endometriosis Image Figure 32. Global Endometriosis Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Oral GnRH Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Oral GnRH Drugs Market Share by Application 2025 VS 2032 Figure 37. North America Oral GnRH Drugs Sales Market Share in Volume by Application in 2025 Figure 38. North America Oral GnRH Drugs Sales Market Share in Value by Application in 2025 Figure 39. Europe Oral GnRH Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Europe Oral GnRH Drugs Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Oral GnRH Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Oral GnRH Drugs Sales Market Share in Value by Application in 2025 Figure 43. Latin America Oral GnRH Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Oral GnRH Drugs Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Oral GnRH Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Oral GnRH Drugs Sales Market Share in Value by Application in 2025 Figure 47. North America Oral GnRH Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Oral GnRH Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Oral GnRH Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Oral GnRH Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Oral GnRH Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Oral GnRH Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Oral GnRH Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Oral GnRH Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Oral GnRH Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Oral GnRH Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Oral GnRH Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Oral GnRH Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Oral GnRH Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Oral GnRH Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Oral GnRH Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Oral GnRH Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Oral GnRH Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Oral GnRH Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Oral GnRH Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Oral GnRH Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Oral GnRH Drugs Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Oral GnRH Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Relugolix
  • Linzagolix
  • Elagolix
  • Others
Applications
  • Menorrhagia
  • Uterine Fibroids
  • Endometriosis
  • Other
Companies covered
  • Pfizer
  • Abbvie
  • Sumitomo Pharma
  • ObsEva
  • JW Pharmaceutical
  • ASKA Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral GnRH Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oral GnRH Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oral GnRH Drugs Market by Type
  6. 1.3.1 Relugolix
  7. 1.3.2 Linzagolix
  8. 1.3.3 Elagolix
  9. 1.3.4 Others
  10. 1.4 Global Oral GnRH Drugs Market Size by Type
  11. 1.4.1 Global Oral GnRH Drugs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Oral GnRH Drugs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Oral GnRH Drugs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Oral GnRH Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Oral GnRH Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Oral GnRH Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Oral GnRH Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Oral GnRH Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oral GnRH Drugs Industry Trends
  2. 2.2 Oral GnRH Drugs Industry Drivers
  3. 2.3 Oral GnRH Drugs Industry Opportunities and Challenges
  4. 2.4 Oral GnRH Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oral GnRH Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Oral GnRH Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Oral GnRH Drugs Price (2021-2026)
  4. 3.4 Global Oral GnRH Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral GnRH Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Oral GnRH Drugs Company, Product Type & Application
  7. 3.7 Global Oral GnRH Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral GnRH Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral GnRH Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral GnRH Drugs Tier 1, Tier 2, and Tier 3
4 Oral GnRH Drugs Regional Status and Outlook
  1. 4.1 Global Oral GnRH Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oral GnRH Drugs Historic Market Size by Region
  3. 4.2.1 Global Oral GnRH Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oral GnRH Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oral GnRH Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oral GnRH Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Oral GnRH Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oral GnRH Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oral GnRH Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oral GnRH Drugs by Application
  1. 5.1 Oral GnRH Drugs Market by Application
  2. 5.1.1 Menorrhagia
  3. 5.1.2 Uterine Fibroids
  4. 5.1.3 Endometriosis
  5. 5.1.4 Other
  6. 5.2 Global Oral GnRH Drugs Market Size by Application
  7. 5.2.1 Global Oral GnRH Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Oral GnRH Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Oral GnRH Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Oral GnRH Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Oral GnRH Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Oral GnRH Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Oral GnRH Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Oral GnRH Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer Oral GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Oral GnRH Drugs Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 Abbvie
  8. 6.2.1 Abbvie Company Information
  9. 6.2.2 Abbvie Business Overview
  10. 6.2.3 Abbvie Oral GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Abbvie Oral GnRH Drugs Product Portfolio
  12. 6.2.5 Abbvie Recent Developments
  13. 6.3 Sumitomo Pharma
  14. 6.3.1 Sumitomo Pharma Company Information
  15. 6.3.2 Sumitomo Pharma Business Overview
  16. 6.3.3 Sumitomo Pharma Oral GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sumitomo Pharma Oral GnRH Drugs Product Portfolio
  18. 6.3.5 Sumitomo Pharma Recent Developments
  19. 6.4 ObsEva
  20. 6.4.1 ObsEva Company Information
  21. 6.4.2 ObsEva Business Overview
  22. 6.4.3 ObsEva Oral GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 ObsEva Oral GnRH Drugs Product Portfolio
  24. 6.4.5 ObsEva Recent Developments
  25. 6.5 JW Pharmaceutical
  26. 6.5.1 JW Pharmaceutical Company Information
  27. 6.5.2 JW Pharmaceutical Business Overview
  28. 6.5.3 JW Pharmaceutical Oral GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 JW Pharmaceutical Oral GnRH Drugs Product Portfolio
  30. 6.5.5 JW Pharmaceutical Recent Developments
  31. 6.6 ASKA Pharmaceutical
  32. 6.6.1 ASKA Pharmaceutical Company Information
  33. 6.6.2 ASKA Pharmaceutical Business Overview
  34. 6.6.3 ASKA Pharmaceutical Oral GnRH Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 ASKA Pharmaceutical Oral GnRH Drugs Product Portfolio
  36. 6.6.5 ASKA Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Oral GnRH Drugs Sales by Country
  2. 7.1.1 North America Oral GnRH Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oral GnRH Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Oral GnRH Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oral GnRH Drugs Market Size by Country
  6. 7.2.1 North America Oral GnRH Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oral GnRH Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Oral GnRH Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oral GnRH Drugs Sales by Country
  2. 8.1.1 Europe Oral GnRH Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oral GnRH Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Oral GnRH Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oral GnRH Drugs Market Size by Country
  6. 8.2.1 Europe Oral GnRH Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oral GnRH Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oral GnRH Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oral GnRH Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Oral GnRH Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oral GnRH Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oral GnRH Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oral GnRH Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Oral GnRH Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oral GnRH Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oral GnRH Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oral GnRH Drugs Sales by Country
  2. 10.1.1 South America Oral GnRH Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oral GnRH Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Oral GnRH Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oral GnRH Drugs Market Size by Country
  6. 10.2.1 South America Oral GnRH Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oral GnRH Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Oral GnRH Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oral GnRH Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Oral GnRH Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oral GnRH Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oral GnRH Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oral GnRH Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Oral GnRH Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oral GnRH Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oral GnRH Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oral GnRH Drugs Value Chain Analysis
  2. 12.1.1 Oral GnRH Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oral GnRH Drugs Production Mode & Process
  7. 12.2 Oral GnRH Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oral GnRH Drugs Distributors
  10. 12.2.3 Oral GnRH Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst